93. Primary biliary cholangitis Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 298 / Drugs : 252 - (DrugBank : 59) / Drug target genes : 35 - Drug target pathways : 115
Primary biliary cholangitis and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
ID | Diseases (Sorted by score) | Score |
---|---|---|
93 | Primary biliary cholangitis | - |
46 | Malignant rheumatoid arthritis | 31.451 |
49 | Systemic lupus erythematosus | 30.027 |
65 | Primary immunodeficiency | 25.630 |
51 | Scleroderma | 20.853 |
56 | Behcet disease | 18.822 |
42 | Polyarteritis nodosa | 18.022 |
96 | Crohn disease | 17.535 |
41 | Giant cell arteritis | 12.761 |
162 | Pemphigoid | 12.761 |
97 | Ulcerative colitis | 12.627 |
50 | Dermatomyositis | 12.536 |
53 | Sjogren syndrome | 12.118 |
85 | Idiopathic interstitial pneumonia | 10.847 |
28 | Systemic amyloidosis | 10.509 |
95 | Autoimmune hepatitis | 10.420 |
2 | Amyotrophic lateral sclerosis | 10.172 |
26 | HTLV-1-associated myelopathy | 9.812 |
284 | Diamond-Blackfan anemia | 9.657 |
160 | Congenital ichthyosis | 9.371 |
11 | Myasthenia gravis | 9.286 |
40 | Takayasu arteritis | 9.078 |
269 | Pyogenic arthritis | 8.989 |
55 | Relapsing polychondritis | 8.810 |
222 | Primary nephrotic syndrome | 8.536 |
271 | Ankylosing spondylitis | 8.468 |
60 | Aplastic anemia | 8.400 |
285 | Fanconi anemia | 8.370 |
19 | Lysosomal storage disease | 8.292 |
331 | Idiopathic multicentric castleman disease | 8.255 |
45 | Eosinophilic granulomatosis with Polyangiitis | 8.067 |
283 | Acquired pure red cell aplasia | 8.067 |
84 | Sarcoidosis | 7.997 |
164 | Oculocutaneous albinism | 7.953 |
107 | Juvenile idiopathic arthritis | 7.862 |
13 | Multiple sclerosis/Neuromyelitis optica | 7.837 |
66 | IgA nephropathy | 6.818 |
266 | Familial mediterranean fever | 6.612 |
224 | Purpura nephritis | 6.326 |
286 | Hereditary sideroblastic anemia | 6.300 |
44 | Wegener granulomatosis | 6.259 |
62 | Paroxysmal nocturnal hemoglobinuria | 6.259 |
20 | Adrenoleukodystrophy | 6.104 |
234 | Peroxisomal disease (except Adrenoleukodystrophy) | 5.943 |
274 | Osteogenesis Imperfecta | 5.355 |
34 | Neurofibromatosis | 5.202 |
210 | Single Ventricle | 5.089 |
228 | Bronchiolitis obliterans | 5.022 |
302 | Leber hereditary optic neuropathy | 5.000 |
61 | Autoimmune hemolytic anemia | 4.721 |
6 | Parkinson disease | 4.618 |
94 | Primary sclerosing cholangitis | 4.427 |
299 | Cystic fibrosis | 4.321 |
151 | Rasmussen encephalitis | 4.286 |
64 | Thrombotic thrombocytopenic purpura | 3.850 |
326 | Osteopetrosis | 3.850 |
39 | Toxic epidermal necrolysis | 3.740 |
43 | Microscopic polyangiitis | 3.159 |
38 | Stevens-Johnson syndrome | 3.017 |
300 | IgG4-related disease | 3.017 |
63 | Idiopathic thrombocytopenic purpura | 2.926 |
36 | Epidermolysis bullosa | 2.836 |
113 | Muscular dystrophy | 2.665 |
226 | Interstitial cystitis with Hunners ulcer | 2.600 |
35 | Pemphigus | 2.384 |
58 | Hypertrophic cardiomyopathy | 2.217 |
265 | Lipodystrophy | 2.176 |
79 | Homozygous familial hypercholesterolemia | 2.032 |
268 | Nakajo-Nishimura syndrome | 2.000 |
325 | Hereditary autoinflammatory syndrome | 2.000 |
263 | Cerebrotendinous xanthomatosis | 2.000 |
257 | Hepatic glycogenosis | 2.000 |
158 | Tuberous sclerosis | 1.881 |
227 | Osler disease | 1.646 |
90 | Retinitis pigmentosa | 1.637 |
270 | Chronic recurrent multifocal osteomyelitis | 1.629 |
256 | Muscle glycogenosis | 1.406 |
310 | Congenital anomalies syndrome | 1.371 |
229 | Autoimmune pulmonary alveolar proteinosis | 1.371 |
172 | Hypophosphatasia | 1.371 |
333 | Hutchinson-Gilford syndrome | 1.057 |
324 | Methylglutaconic aciduria | 1.000 |
260 | Sitosterolemia | 1.000 |
52 | Mixed connective tissue disease | 1.000 |
220 | Rapidly progressive glomerulonephritis | 1.000 |
30 | Distal myopathy | 1.000 |